Phase III trial of AN 2728 in patients with mild-to-moderate plaque-type psoriasis.
Phase of Trial: Phase III
Latest Information Update: 07 Feb 2012
At a glance
- Drugs Crisaborole (Primary)
- Indications Psoriasis
- Focus Registrational; Therapeutic Use
- 07 Feb 2012 Planned iniatiation date deferred due to company's intention to focus on development for atopic dermatitis, according to an Anacor Pharmaceuticals media release.
- 23 Mar 2011 Planned initiation date changed to 1 Dec 2011.
- 16 Jun 2010 New trial record